News: medical research
South Australian biotech company GPN Vaccines in collaboration with the University of Adelaide has developed a new, universal vaccine against the deadly bacterium Streptococcus pneumoniae.
The University of Adelaide has been awarded $6 million for six research projects to investigate issues including fertility, mastitis and orthopaedic infections.
The University of Adelaide has been awarded more than $8.8 million in research grants from the Federal Government’s Medical Research Future Fund’s (MRFF) to support targeted research on new ways to address risk factors for chronic and complex diseases.
More than $3 million has been awarded to the University of Adelaide’s Robinson Research Institute to identify the predisposing conditions and potentially modifiable factors that can substantially reduce the risk of congenital heart defects. The funding is from the Federal Government’s Medical Research Future Fund’s (MRFF) Cardiovascular Health Mission to boost research into heart disease and stroke. The funding will allow further critical research on understanding the range of factors that contribute to congenital heart defects affecting the lives of many children.